GOVX

GeoVax Labs Inc. Common Stock (GOVX)

Stock · NASDAQ · Health Care

$0.721as of 8/28/2026

Active signals

High Beta100.0%
Resistance level
$1.14
Industry
Biotechnology: Pharmaceutical Preparations

About GOVX

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phas…

Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Employees
19

Fundamentals

1-day range
$0.68$0.7274
Market cap
$5.34M
P/E (trailing)
P/E (forward)
-0.84
EPS (trailing)
$-13.92
Dividend yield
Beta
3.74
Avg. volume
742.1K
Dividend pay date
September 25, 2020
52-week range
$0.59$19.2
Next earnings: March 23, 2026 · EPS estimate $-5.35confirmed

How GeoVax Labs Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$2.49MR&D$18.12M (728%)SG&A$6.01M (241%)GOVX

Source: 10-K filed Apr 15, 2026 · via SEC EDGAR / Finnhub

Forecasts

2 analyst ratings

Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$10
+1287.0%
Median
$10
+1287.0%
Low
$10
+1287.0%

GeoVax Labs Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • GOVX
    GeoVax Labs Inc. Common Stock
    $0.7195
    ▲ 0.35%
    Market cap $5.34MP/E
    $0.59$19.2
  • BGMS
    Bio Green Med Solution Inc. Common Stock
    $0.86
    ▼ 3.37%
    Market cap $5.35MP/E 0.18
    $0.5664$8.82
  • LABT
    Lakewood-Amedex Biotherapeutics Inc. Common Stock
    $2.3
    ▼ 4.56%
    Market cap $5.12MP/E
    $0.366$9.82
  • ERNA
    Ernexa Therapeutics Inc. Common Stock
    $4.57
    ▼ 4.99%
    Market cap $5.09MP/E
    $3.18$71.5
  • NCNA
    NuCana plc American Depositary Share
    $1.79
    ▲ 21.43%
    Market cap $5.62MP/E 0.01
    $1.21$7.22
  • JUNS
    Jupiter Neurosciences Inc. Common Stock
    $4.59
    ▼ 6.13%
    Market cap $5.65MP/E
    $4.1$138
  • APVO
    Aptevo Therapeutics Inc. Common Stock
    $2.36
    ▼ 2.48%
    Market cap $4.92MP/E 0.00
    $2.3$48.78

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions
Acquired
135.7K
Disposed
0
  • Morgan Jayne · June 17, 2026 · Grant
    6.0K
  • Lemerond Nicole · June 17, 2026 · Grant
    6.0K
  • McKee Kelly T. Jr. · June 17, 2026 · Grant
    17.6K
  • Sharkey John W. · June 17, 2026 · Grant
    17.6K
  • Kollintzas Dean G · June 17, 2026 · Grant
    6.0K
  • Reynolds Mark · June 17, 2026 · Grant
    17.6K
  • SPENCER JOHN N JR · June 17, 2026 · Grant
    6.0K
  • NEWMAN MARK J · June 17, 2026 · Grant
    17.6K
  • DODD DAVID A · June 17, 2026 · Grant
    29.3K
  • CHASE RANDAL D · June 17, 2026 · Grant
    6.0K
  • MCNALLY ROBERT T · June 17, 2026 · Grant
    6.0K

Institutional Ownership

March 31, 2026

Total shares held
328.3K
Total value held
$438.6K
Institutional holders
15
Top holders this quarter
  • Unknown269.3K
  • Unknown36.1K
  • Unknown10.5K
  • Unknown4.2K
  • Unknown3.5K
  • Unknown3.2K
  • Unknown1.1K
  • Unknown384
  • Unknown31
  • Unknown6

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.